Aaron K. Olson, MD

Cardiology

On staff since July 2006

Academic Title: Assistant Professor, Division of Cardiology, Department of Pediatrics

Research Center: Center for Developmental Therapeutics

"I go to work each day striving to make new discoveries in the basic science mechanisms controlling cardiovascular disease in children. I hope to translate these discoveries into new therapies for pediatric patients. "

Aaron Olson, MD, is an attending physician at Seattle Children’s Hospital and Assistant Professor in the Department of Pediatrics at the University of Washington School of Medicine. His clinical work is in general pediatric cardiology. His research interests include pharmacological clinical trials and metabolic regulation in the heart.

Recommendations

Be the first to recommend Dr. Aaron Olson

Overview
Publications
Presentations
Research Funding

Overview

Board Certification(s): Pediatrics
Pediatric Cardiology
Medical/Professional School: University of Minnesota Medical School, Minneapolis
University of Minnesota - Duluth School of Medicine, Duluth
Residency: Pediatrics, University of Chicago , Chicago
Fellowship: Pediatric Cardiology, University of Iowa Hospitals and Clinics, Iowa City
Pediatric Cardiology, University of Iowa Hospitals and Clinics, Iowa City
Clinical Interests: Neonatal heart disease
Research Focus Area: Cardiac Metabolism, Kawasaki Disease, Cardiac Hypertrophy, Genetic Cardiovascular Disease

Publications

Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease.
The Journal of pediatrics , 2010 Dec: 960-966.e1

Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.
Circulation , 2010 Sep 14: S224-33

Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease.
The Journal of pediatrics , 2010 Jul 26

Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion.
American journal of physiology. Heart and circulatory physiology , 2008 Dec: H2315-20

Cardioselective dominant-negative thyroid hormone receptor (Delta337T) modulates myocardial metabolism and contractile efficiency.
American journal of physiology. Endocrinology and metabolism , 2008 Aug: E420-7

Activation of the mitogen-activated protein kinases and Akt in response to pulmonary artery banding in the fetal sheep heart is developmentally regulated.
Neonatology , 2008: 145-52

Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heart.
American journal of physiology. Heart and circulatory physiology , 2006 Apr: H1587-95

The mitogen-activated protein kinases and Akt are developmentally regulated in the chronically anemic fetal sheep heart.
Journal of the Society for Gynecologic Investigation , 2006 Apr: 157-65

Presentations

Presentations Title	Event	Location	Date
Metabolic Substrate Utilization During C-Myc Induced Cardiac Hypertrophy			July 1, 2009

Research Funding

Grant Title	Grantor	Amount	Award Date
The Marfan Trial- a Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan) in individuals with Marfan syndrome (MFS)	National Institute of Health	$unknown	Feb. 1, 2008
Role of Fcgamma Receptor Polymorphisms in Determining IVIG Response in Kawasaki Disease	Thrasher Foundation		Jan. 1, 2008

Seattle Children’s provides healthcare for the special needs of children regardless of race, sex, creed, ethnicity or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.

4800 Sand Point Way NE

Seattle

98105

206-987-2000

866-987-2000 (toll-free)

206-987-2280 (TTY)